253 related articles for article (PubMed ID: 25939485)
1. PGMD: a comprehensive manually curated pharmacogenomic database.
Kaplun A; Hogan JD; Schacherer F; Peter AP; Krishna S; Braun BR; Nambudiry R; Nitu MG; Mallelwar R; Albayrak A
Pharmacogenomics J; 2016 Apr; 16(2):124-8. PubMed ID: 25939485
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
[TBL] [Abstract][Full Text] [Related]
3. Pakistan Genetic Mutation Database (PGMD); A centralized Pakistani mutome data source.
Qasim I; Ahmad B; Khan MA; Khan N; Muhammad N; Basit S; Khan S
Eur J Med Genet; 2018 Apr; 61(4):204-208. PubMed ID: 29223505
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements.
Shekhani R; Steinacher L; Swen JJ; Ingelman-Sundberg M
Clin Pharmacol Ther; 2020 May; 107(5):1240-1255. PubMed ID: 31715018
[TBL] [Abstract][Full Text] [Related]
5. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic information in drug labels: European Medicines Agency perspective.
Ehmann F; Caneva L; Prasad K; Paulmichl M; Maliepaard M; Llerena A; Ingelman-Sundberg M; Papaluca-Amati M
Pharmacogenomics J; 2015 Jun; 15(3):201-10. PubMed ID: 25707393
[TBL] [Abstract][Full Text] [Related]
7. How to Consider Rare Genetic Variants in Personalized Drug Therapy.
Lauschke VM; Ingelman-Sundberg M
Clin Pharmacol Ther; 2018 May; 103(5):745-748. PubMed ID: 29313952
[TBL] [Abstract][Full Text] [Related]
8. Copy number variants and pharmacogenomics.
Ouahchi K; Lindeman N; Lee C
Pharmacogenomics; 2006 Jan; 7(1):25-9. PubMed ID: 16354122
[TBL] [Abstract][Full Text] [Related]
9. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Hodge AE; Altman RB; Klein TE
Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
[TBL] [Abstract][Full Text] [Related]
10. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
Gong L; Whirl-Carrillo M; Klein TE
Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.
Kim T; Han N; Sohn M; Oh JM; Lee EK; Ji E; Kim IW
Basic Clin Pharmacol Toxicol; 2015 May; 116(5):438-44. PubMed ID: 25348905
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of the G protein-coupled receptors.
Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
[TBL] [Abstract][Full Text] [Related]
13. Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
Georgitsi M; Viennas E; Gkantouna V; Christodoulopoulou E; Zagoriti Z; Tafrali C; Ntellos F; Giannakopoulou O; Boulakou A; Vlahopoulou P; Kyriacou E; Tsaknakis J; Tsakalidis A; Poulas K; Tzimas G; Patrinos GP
Pharmacogenomics; 2011 Jan; 12(1):49-58. PubMed ID: 21174622
[TBL] [Abstract][Full Text] [Related]
14. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
Georgitsi M; Patrinos GP
Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
[TBL] [Abstract][Full Text] [Related]
16. PACdb: a database for cell-based pharmacogenomics.
Gamazon ER; Duan S; Zhang W; Huang RS; Kistner EO; Dolan ME; Cox NJ
Pharmacogenet Genomics; 2010 Apr; 20(4):269-73. PubMed ID: 20216476
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic biomarkers in drug labels: what do they tell us?
Tutton R
Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709
[TBL] [Abstract][Full Text] [Related]
20. Progress towards the integration of pharmacogenomics in practice.
Mooney SD
Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
